Osiris Biomed 3D Awarded $10,000 First Prize For 3D-Printed Implant Development
Osiris Biomed 3D has applied for a patent for single anesthetic reconstructive surgery, a software and hardware ecosystem that will use patients’ 3D scanning and DICOMM data to produce a custom device or implant to be sterilized and surgically implanted on the operating table in real time all in one surgery. The company was founded by CEO Theodore Gerstle, MD, a 1999 United States Military Academy graduate, COO Christopher Gerstle, Esq, and VP Nathan Gargus, MD, a 2000 Academy graduate.
The contest was held at the Hub in Philadelphia. Much like in the now hugely popular television show, five contestants were asked to pitch their business ideas to a panel of local CEOs and compete for funding. The contestants were all U.S. military veterans, and the winners presented a project which could drastically change and improve surgical procedures on and off the battlefield.
